Cargando…
Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma
BACKGROUND: Elevated serum YKL-40 levels have been observed in various cancers. We evaluated the diagnostic performance of serum YKL-40 alone or in combination with the CEA, CYFRA21-1 and SCCA tumor markers for patients with esophageal squamous cell carcinoma (ESCC). METHODS: YKL-40 was detected in...
Autores principales: | Zheng, Xin, Xing, Shan, Liu, Xiao-Min, Liu, Wen, Liu, Dan, Chi, Pei-Dong, Chen, Hao, Dai, Shu-Qin, Zhong, Qian, Zeng, Mu-Sheng, Liu, Wan-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094903/ https://www.ncbi.nlm.nih.gov/pubmed/25001061 http://dx.doi.org/10.1186/1471-2407-14-490 |
Ejemplares similares
-
Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999) -
Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma
por: Catanzaro, Joseph M., et al.
Publicado: (2011) -
Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011) -
Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2
por: Yin, Lei, et al.
Publicado: (2010) -
High YKL-40 Serum Concentration Is Correlated with Prognosis of Chinese Patients with Breast Cancer
por: Wang, Dong, et al.
Publicado: (2012)